Business News • PR NewsWire • Neupro® (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease

Neupro® (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease

Neupro® (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease

BRUSSELS, June 17 /PRNewswire-FirstCall/ -- New data presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina (June 13-17, 2010) showed that Neupro® (rotigotine transdermal system) provided significantly greater improvement

View More : http://www.prnewswire.com/news-releases/neupro-rotigotine-transdermal-system-showed-significant-benefit-on-early-morning...

Releted News by prnewswire

Truphone(TM) Announces Agreements With Vodafone Netherlands and Orange in Spain

ASE Files 2009 Annual Report on Form 20-F

Awaken, Restore, or Relax at The Vitamin Shoppe With New Solixir® Botanical Beverages

The Female Health Company to Present at Sidoti Micro Cap Conference